Stage Iib Non-small Cell Lung Cancer

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2025-11-12
Clinical Trial Update: Magnetic Resonance-Guided Hypofractionated Adaptive Radiation Therapy With Concurrent Chemotherapy and Consolidation Durvalumab for Inoperable Stage IIB, IIIA, and Select IIIB and IIIC Non-small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating MRI-guided adaptive radiation therapy with concurrent chemotherapy and consolidation durvalumab in inoperable Stage…
CLINICAL_TRIALS trial_result · 2025-06-12
Clinical Trial Update: Hypofractionated Boost Before Chemoradiation for Patients With Stage II-III Non-small Cell Lung Cancer Unsuitable for Surgery [Phase 2]
This Phase 2 clinical trial update reports results for a hypofractionated boost before chemoradiation in patients with stage II–III non-smal…